A 76-year-old male who was 169.7 cm tall and who weighed 65.2 kg was scheduled for robot-assisted radical prostatectomy under general anesthesia. He had no specific past medical history but suffered infrequent atypical chest pain. Preoperative transthoracic echocardiography (TTE) and an electrocardiogram (ECG) for cardiologic evaluation were done, with no abnormal findings except sinus bradycardia. The results of chest X-ray examination, pulmonary function testing, and other preoperative laboratory tests were normal. The patient entered the operating room without premedication. ECG, non-invasive blood pressure (NIBP), end-tidal carbon dioxide, and oxygen saturation (SpO
2) were monitored. The patient's initial vital signs were: NIBP, 125/67 mmHg; SpO
2, 98%; and heart rate, 64 beats/min. General anesthesia was induced with 120 mg propofol (Anepol®, Hana pharm, Hwaseong, Korea) and 50 mg rocuronium (Esmeron®, N.V. Organon, Oss, Netherlands). Mask ventilation was applied with 100% oxygen, and tracheal intubation was done without incident 2 minutes after rocuronium administration. The anesthesia was maintained with 6 volume % desflurane (Suprane®, Baxter Healthcare, Puerto Rico, USA) and remifentanil (Ultiva®, Glaxosmithkline, San Polo, Italy) infusion at 0.1 µg/kg/min. A right internal jugular vein catheter was inserted for fluid or blood administration, and the patient's continuous central venous pressure (CVP) was monitored. Invasive arterial blood pressure was monitored at the right radial artery, and the FloTrac/Vigileo™ system (Edwards Lifesciences, Irvine, CA, USA) was used to monitor the stroke volume variance (SVV) and cardiac index (CI). The operation was done in a steep Trendelenberg position at an angle of 45 degrees. The patient's intraoperative vital signs were maintained within the following ranges: systolic blood pressure, 90–100 mmHg; CVP, 10–15 mmHg; SVV, 10–15%; CI, 2.0–2.5; and body temperature, 35.5–36.0℃. The operation was completed uneventfully and took 4 hours and 15 minutes. At the time when the pneumoperitoneum was removed and the patient was taken out of the trendelenberg position, his blood pressure and heart rate had not changed significantly. An additional 50 mg of rocuronium was administered during the operation to maintain muscle relaxation, so the total dose of rocuronium was 100 mg. The total fluid input was 3,100 ml (500 ml colloid and 2,600 ml crystalloid), and the estimated bleeding count was 570 ml. We stopped administration of desflurane and remifentanil. After 5 minutes, the patient's train-of-four (TOF) was 2; we gave him 130 mg sugammadex (Bridion®, N.V. Organon, Oss, Netherlands). Two minutes later, sudden ventricular premature contraction (VPC) bigeminy appeared on the ECG, the heart rate decreased to below 40 /min, and the systolic blood pressure decreased to below 60 mmHg. Despite the administration of 10 mg ephedrine and 80 mg lidocaine i.v., the heart rate remained under 20 /min. After immediate chest compression for 10 seconds and administration of 0.5 mg atropine i.v., the patient's vital signs returned to the baseline values. Three µg/kg/min isosorbide dinitrate was infused to prevent myocardial ischemia. After 10 minutes, the patient's heart rate and blood pressure decreased, and we gave him 10 mg ephedrine. The patient did not respond, and cardiac arrest developed again. We initiated cardiopulmonary resuscitation (CPR) within seconds; other anesthesiology and cardiology staff arrived to help. During CPR, 1 mg epinephrine was given i.v., and ventricular tachycardia (VT) occurred. The patient was immediately cardioverted with 200 J, but he did not respond and CPR was continued. Over the 10 minutes during which CPR was performed, an additional dose of 1 mg epinephrine was given i.v. twice, cardioversion with 200 J was done twice, and 0.4 mg nitroglycerin was given i.v.; the patient's ECG showed a sinus rhythm of 110 /min. Dopamine and norepinephrine were infused to maintain normal blood pressure and cardiac output. After 10 minutes, VT recurred; 200 J cardioversion was delivered immediately and 2 g magnesium was given i.v. The patient recovered directly; his ECG showed a sinus rhythm with mild tachycardia and a heart rate of 90–100 /min. We monitored the patient for 30 minutes, during which time his vital signs were kept stable with dopamine infusion at 5 µg/kg/min and norepinephrine infusion at 0.25 µg/kg/min. The patient was transferred to the intensive care unit. His arterial blood gas and electrolytes were checked; all values were within the normal limits, including a serum magnesium level of 2.1 mg/dl. His myoglobin was elevated to 302.9 ng/ml, and his CK-MB/troponin I level was normal on the day of the operation. On postoperative day 1, his CK-MB/troponin I level was increased to 15.6/8.21 ng/ml; coronary angiography was done, which showed coronary artery obstructive disease. Concentric tubular stenotic lesions in the right coronary artery and left circumflex artery, which blocked 40% and 50% of the blood flow, respectively, were observed. Also, a coronary spasm was observed on the ergonovine test, and the patient was diagnosed with variant angina (
Fig. 1). The ECG results of the VPC bigeminy obtained from the ergonovine test were similar to those obtained in the two minutes after sugammadex administration (
Fig. 2). On postoperative day 1, the patient's trachea was extubated; oxygen saturation was maintained well with spontaneous respiration. On postoperative day 2, the patient's blood pressure was normal without vasopressors. The patient was transferred to the general ward on postoperative day 2. On postoperative day 8, the patient was discharged uneventfully with normal ECG and laboratory results. After 4 weeks, the patient visited our outpatient clinic; intradermal testing was done with a 1 : 100 dilution of sugammadex 100 mg/ml, rocuronium (1 : 50) and sugammadex-rocuronium complex, and the results were negative.